226 related articles for article (PubMed ID: 18805962)
1. Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients.
Federici AB; Mannucci PM; Castaman G; Baronciani L; Bucciarelli P; Canciani MT; Pecci A; Lenting PJ; De Groot PG
Blood; 2009 Jan; 113(3):526-34. PubMed ID: 18805962
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic Parameters in Genotypically Selected Type 2B von Willebrand Disease Patients: A Large, Single-Center Experience Including a New Novel Mutation.
Woods AI; Kempfer AC; Paiva J; Sanchez-Luceros A; Bermejo E; Chuit R; Alberto MF; Blanco AN; Lazzari MA
Semin Thromb Hemost; 2017 Feb; 43(1):92-100. PubMed ID: 27978591
[TBL] [Abstract][Full Text] [Related]
3. A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis.
Casonato A; Sartorello F; Pontara E; Gallinaro L; Bertomoro A; Grazia Cattini M; Daidone V; Szukowska M; Pagnan A
Thromb Haemost; 2007 Dec; 98(6):1182-7. PubMed ID: 18064311
[TBL] [Abstract][Full Text] [Related]
4. Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation.
Casonato A; Steffan A; Pontara E; Zucchetto A; Rossi C; De Marco L; Girolami A
Thromb Haemost; 1999 Feb; 81(2):224-8. PubMed ID: 10063996
[TBL] [Abstract][Full Text] [Related]
5. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
[TBL] [Abstract][Full Text] [Related]
6. Type 2B Hiroshima: a variant of von Willebrand disease characterized by chronic thrombocytopenia and the presence of all von Willebrand factor multimers in plasma.
Takimoto Y; Imanaka F
Int J Hematol; 1999 Aug; 70(2):127-31. PubMed ID: 10497852
[TBL] [Abstract][Full Text] [Related]
7. Higher and lower active circulating VWF levels: different facets of von Willebrand disease.
Casonato A; Pontara E; Morpurgo M; Sartorello F; De Groot PG; Cattini MG; Daidone V; De Marco L
Br J Haematol; 2015 Dec; 171(5):845-53. PubMed ID: 26456374
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.
Frontroth JP; Hepner M; Sciuccati G; Feliú Torres A; Pieroni G; Bonduel M
Thromb Haemost; 2010 Dec; 104(6):1158-65. PubMed ID: 20941465
[TBL] [Abstract][Full Text] [Related]
9. Type 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality.
Castaman G; Federici AB
Semin Thromb Hemost; 2016 Jul; 42(5):478-82. PubMed ID: 27148840
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of type 2 von Willebrand disease.
Fressinaud E; Mazurier C; Meyer D
Int J Hematol; 2002 Jan; 75(1):9-18. PubMed ID: 11843298
[TBL] [Abstract][Full Text] [Related]
11. A family having type 2B von Willebrand disease with an R1306W mutation: Severe thrombocytopenia leads to the normalization of high molecular weight multimers.
Ozeki M; Kunishima S; Kasahara K; Funato M; Teramoto T; Kaneko H; Fukao T; Kondo N
Thromb Res; 2010 Feb; 125(2):e17-22. PubMed ID: 19740526
[TBL] [Abstract][Full Text] [Related]
12. Type 2B vWD: the varied clinical manifestations in two kindreds.
Mathew P; Greist A; Maahs JA; Lichtenberg EC; Shapiro AD
Haemophilia; 2003 Jan; 9(1):137-44. PubMed ID: 12558793
[TBL] [Abstract][Full Text] [Related]
13. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
de Romeuf C; Hilbert L; Mazurier C
Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetics of von Willebrand disease.
Mazurier C; Ribba AS; Gaucher C; Meyer D
Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
[TBL] [Abstract][Full Text] [Related]
15. A first Taiwanese Chinese family of type 2B von Willebrand disease with R1306W mutation.
Shen MC; Lin JS; Lin DS; Hsu SC; Lin B
Thromb Res; 2003; 112(5-6):291-5. PubMed ID: 15041272
[TBL] [Abstract][Full Text] [Related]
16. [From gene to disease; from mutations in the Von Willebrand factor gene to hemorrhagic diathesis and thrombocytopenia].
Gómez García EB; Brouwers GJ; Leebeek FW
Ned Tijdschr Geneeskd; 2002 Jun; 146(25):1180-2. PubMed ID: 12109309
[TBL] [Abstract][Full Text] [Related]
17. A novel platelet-type von Willebrand disease mutation (GP1BA p.Met255Ile) associated with type 2B "Malmö/New York" von Willebrand disease.
Lavenu-Bombled C; Guitton C; Dupuis A; Baas MJ; Desconclois C; Dreyfus M; Li R; Caron C; Gachet C; Fressinaud E; Lanza F
Thromb Haemost; 2016 Nov; 116(6):1070-1078. PubMed ID: 27683759
[TBL] [Abstract][Full Text] [Related]
18. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
[TBL] [Abstract][Full Text] [Related]
19. Acquired von Willebrand Syndrome Hiding Inherited von Willebrand Disease Can Explain Severe Bleeding in Patients With Aortic Stenosis.
Casonato A; Galletta E; Cella G; Barbon G; Daidone V
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2187-2194. PubMed ID: 32640909
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy-induced worsening of thrombocytopenia in a patient with type IIB von Willebrand's disease.
Casonato A; Sartori MT; Bertomoro A; Fede T; Vasoin F; Girolami A
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):33-40. PubMed ID: 1772996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
